Oct 13 (Reuters) - U.S. drug inspectors uncovered serious quality control problems at an Eli Lilly and Co (LLY.N), opens new tab pharmaceutical plant that is ramping up to manufacture one of two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback